Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Rxo (RXO) Long-Term Debt Repayments (2023 - 2025)

Historic Long-Term Debt Repayments for Rxo (RXO) over the last 3 years, with Q4 2025 value amounting to $1.0 million.

  • Rxo's Long-Term Debt Repayments changed N/A to $1.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.0 million, marking a year-over-year decrease of 9714.29%. This contributed to the annual value of $2.0 million for FY2025, which is 3333.33% down from last year.
  • Latest data reveals that Rxo reported Long-Term Debt Repayments of $1.0 million as of Q4 2025.
  • Over the past 5 years, Rxo's Long-Term Debt Repayments peaked at $101.0 million during Q4 2023, and registered a low of $1.0 million during Q4 2025.
  • For the 3-year period, Rxo's Long-Term Debt Repayments averaged around $26.5 million, with its median value being $2.0 million (2023).
  • Over the last 5 years, Rxo's Long-Term Debt Repayments had its largest YoY gain of 0.0% in 2024, and its largest YoY loss of 0.0% in 2024.
  • Quarter analysis of 3 years shows Rxo's Long-Term Debt Repayments stood at $101.0 million in 2023, then crashed by 98.02% to $2.0 million in 2024, then tumbled by 50.0% to $1.0 million in 2025.
  • Its Long-Term Debt Repayments stands at $1.0 million for Q4 2025, versus $2.0 million for Q3 2024 and $101.0 million for Q4 2023.